Sort by
Refine Your Search
-
new cures to the world’s deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our
-
new cures to the world's deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our
-
Max Planck Institute of Animal Behavior, Radolfzell / Konstanz | Konstanz, Baden W rttemberg | Germany | about 1 month ago
virtual-reality experiments with insects, development of new models of neural or embodied dynamics, comparative analyses across species, or novel methodological approaches aligned with the central questions
-
new cures to the world’s deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our
-
new cures to the world's deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our
-
new cures to the world’s deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our
-
teaching in the field of flexibility, advanced power electronics, battery energy systems and microgrids. We are currently formed by 30 researchers from 15 different countries, which continuously provide us
-
Postdoc position in method development in human statistical genetics, with a focus on classificat...
based on genetic data: “Many common diseases are highly heterogeneous, meaning that two individuals can be diagnosed with the same disease but have very different progressions or respond very differently
-
and acceptance of innovative multifunctional land use solutions, and on how such solutions are perceived, debated, and accepted by different stakeholder groups. The starting date is August 1, 2026
-
based on genetic data: “Many common diseases are highly heterogeneous, meaning that two individuals can be diagnosed with the same disease but have very different progressions or respond very differently